The purpose of this study was to determine the salivary levels and tissue expression of HER2/neu in patients with head and neck squamous cell carcinoma (HNSCC) and their correlation with clinicopathologic parameters. The gene discussed is ERBB2; the disease is head and neck squamous cell carcinoma.